Clinical Trial

AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 13, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the clinical utility of combining the albumin to globulin ratio (AGR) and the prognostic nutritional index (PNI) as a predictive model for assessing disease activity in patients with systemic lupus erythematosus (SLE). By correlating these nutritional and inflammatory markers with clinical manifestations and laboratory parameters, we hope to establish a simple, non-invasive, and cost-effective tool to aid in monitoring disease activity in Systemic lupus erythematosus patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-26.
Status change: Not Yet Recruiting → Recruiting 2026-05-10
Trial Details
NCT Number NCT07043153
Lead Sponsor Sohag University
Conditions Systemic Lupus Erythematosus Disease
Enrollment 200 participants
Start Date 2025-08-05
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-13